A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

Clinical trial NCT07029217 · RECRUITING

Trial details

NCT number: NCT07029217
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Follicular Lymphoma Marginal Zone Lymphoma

Start date: 2025-06-09
Primary completion: 2028-06-01
Enrollment: 375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.